Impaired development and dysfunction of endothelial progenitor cells in type 2 diabetic mice

Isner, 1999, Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization, J Clin Invest, 103, 1231, 10.1172/JCI6889 Asahara, 1999, Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization, Circ Res, 85, 221, 10.1161/01.RES.85.3.221 Rafii, 2003, Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration, Nat Med, 9, 702, 10.1038/nm0603-702 Kalka, 2000, Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization, Proc Natl Acad Sci U S A, 97, 3422, 10.1073/pnas.97.7.3422 Kawamoto, 2003, Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia, Circulation, 107, 461, 10.1161/01.CIR.0000046450.89986.50 Cho, 2003, Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelialization and reduce vascular inflammation after intravascular radiation, Circulation, 108, 2918, 10.1161/01.CIR.0000097001.79750.78 Hill, 2003, Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. J Med, 348, 593 Penn, 2001, Tissue factor, the emerging link between inflammation, thrombosis, and vascular remodeling, Circ Res, 89, 1, 10.1161/hh1301.093825 Surdacki, 2007, Nontraditional atherosclerotic risk factors and extent of coronary atherosclerosis in patients with combined impaired fasting glucose and impaired glucose tolerance, Metabolism, 56, 77, 10.1016/j.metabol.2006.08.023 Sheetz, 2002, Molecular understanding of hyperglycemia's adverse effects for diabetic complications, JAMA, 288, 2579, 10.1001/jama.288.20.2579 Saad, 2015, Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells, Endocrine, 50, 537, 10.1007/s12020-015-0709-4 Loomans, 2004, Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes, Diabetes, 53, 195, 10.2337/diabetes.53.1.195 Tepper, 2002, Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures, Circulation, 106, 2781, 10.1161/01.CIR.0000039526.42991.93 Asahara, 2004, Endothelial progenitor cells for postnatal vasculogenesis, Am J Physiol Cell Physiol, 287, C572, 10.1152/ajpcell.00330.2003 Masuda, 2013, Clonogenic assay of endothelial progenitor cells, Trends Cardiovasc Med, 23, 99, 10.1016/j.tcm.2012.09.007 Tsukada, 2013, Identification of mouse colony-forming endothelial progenitor cells for postnatal neovascularization: a novel insight highlighted by new mouse colony-forming assay, Stem Cell Res Ther, 4, 20, 10.1186/scrt168 Masuda, 2011, Methodological development of a clonogenic assay to determine endothelial progenitor cell potential, Circ Res, 109, 20, 10.1161/CIRCRESAHA.110.231837 Kwon, 2011, Differential activity of bone marrow hematopoietic stem cell subpopulations for EPC development and ischemic neovascularization, J Mol Cell Cardiol, 51, 308, 10.1016/j.yjmcc.2011.04.007 Li, 2006, Enhanced proatherogenic responses in macrophages and vascular smooth muscle cells derived from diabetic db/db mice, Diabetes, 55, 2611, 10.2337/db06-0164 O’Connor, 2005, IL-1beta-mediated innate immunity is amplified in the db/db mouse model of type 2 diabetes, J Immunol, 174, 4991, 10.4049/jimmunol.174.8.4991 Zykova, 2000, Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice, Diabetes, 49, 1451, 10.2337/diabetes.49.9.1451 Fadini, 2006, Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy, Arterioscler Thromb Vasc Biol, 26, 2140, 10.1161/01.ATV.0000237750.44469.88 Tamarat, 2004, Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment, Am J Pathol, 164, 457, 10.1016/S0002-9440(10)63136-7 Asahara, 1999, VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells, EMBO J, 18, 3964, 10.1093/emboj/18.14.3964 Yamaguchi, 2003, Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization, Circulation, 107, 1322, 10.1161/01.CIR.0000055313.77510.22 Ceradini, 2004, Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1, Nat Med, 10, 858, 10.1038/nm1075 De Falco, 2004, SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells, Blood, 104, 3472, 10.1182/blood-2003-12-4423 Segal, 2006, Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes, Diabetes, 55, 102, 10.2337/diabetes.55.01.06.db05-0803 Nikolic, 2004, Bone marrow precursors of nonobese diabetic mice develop into defective macrophage-like dendritic cells in vitro, J Immunol, 173, 4342, 10.4049/jimmunol.173.7.4342 Chilton, 2005, Hematopoietic stem cells from NOD mice exhibit autonomous behavior and a competitive advantage in allogeneic recipients, Blood, 105, 2189, 10.1182/blood-2004-07-2757 Hotamisligil, 2006, Inflammation and metabolic disorders, Nature, 444, 860, 10.1038/nature05485 Shoelson, 2006, Inflammation and insulin resistance, J Clin Invest, 116, 1793, 10.1172/JCI29069 Wellen, 2005, Inflammation, stress, and diabetes, J Clin Invest, 115, 1111, 10.1172/JCI25102 Dandona, 2004, Inflammation: the link between insulin resistance, obesity and diabetes, Trends Immunol, 25, 4, 10.1016/j.it.2003.10.013 Halaas, 1995, Weight-reducing effects of the plasma protein encoded by the obese gene, Science, 269, 543, 10.1126/science.7624777 Lee, 1996, Abnormal splicing of the leptin receptor in diabetic mice, Nature, 379, 632, 10.1038/379632a0 Hayase, 1996, Regulation of obese gene expression in KK mice and congenic lethal yellow obese KKAy mice, Am J Physiol, 271, E333 Hounsom, 1997, Does neuropathy develop in animal models?, Clin Neurosci, 4, 380 Stepanovic, 2003, Leprdb diabetic mouse bone marrow cells inhibit skin wound vascularization but promote wound healing, Circ Res, 92, 1247, 10.1161/01.RES.0000074906.98021.55 Awad, 2005, Obese diabetic mouse environment differentially affects primitive and monocytic endothelial cell progenitors, Stem Cells, 23, 575, 10.1634/stemcells.2004-0185